Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1100598-32-0
Purity
95%
Tepotinib is an oral tyrosine kinase inhibitor targeted against MET (Hepatocyte growth factor receptor) for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations.
Properties
Name
Tepotinib
Smiles
CN1CCC(COC=2C=NC(=NC2)C=3C=CC=C(CN4N=C(C=CC4=O)C=5C=CC=C(C#N)C5)C3)CC1
Targets
Please log in to see this information
SDS
EMD 1214063 | MSC2156119 | MSC2156119J | tepotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$85
2 mg
$98
5 mg
$130
10 mg
$226
15 mg
$273
20 mg
$321
25 mg
$390
30 mg
$460
35 mg
$529
40 mg
$599
45 mg
$642
50 mg
$685
75 mg
$910
100 mg
$POA
Quantity
1
Total amount
$ 130
EMD 1214063 | MSC2156119 | MSC2156119J | tepotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.